Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
May 15, 2024
BUY40.402k0.0157%ARKK
May 14, 2024
BUY28.830k0.0116%ARKK
May 10, 2024
BUY200.395k0.0757%ARKK
May 9, 2024
BUY50.535k0.0187%ARKK
March 26, 2024
BUY29.308k0.01%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
3.06%$2.53b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
11🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
14$62.04
🎫ARK Ownership Percent
8.14%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA